Sensydia

Sensydia is committed to developing technologies that enable rapid, non-invasive diagnosis and management of heart disease patients. Sensydia integrates expertise in clinical cardiology, biomedical engineering, and machine learning to develop fast, wireless cardiac function monitoring. The company’s CPS system is made possible through advancements in machine learning, preclinical studies, clinical trials, and years of experience in cardiac intensive care. Sensydia's mission is to provide rapid, easy-to-use, non-invasive monitoring of key cardiac performance indicators to reduce readmissions, lower care costs, and improve outcomes for heart disease patients.